Cellectis S.A. Files Form 6-K
Ticker: CLLS · Form: 6-K · Filed: Oct 7, 2025 · CIK: 1627281
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: CLLS
TL;DR
Cellectis S.A. (CLLS) filed a 6-K on Oct 7, 2025, confirming its foreign private issuer status.
AI Summary
Cellectis S.A. filed a Form 6-K on October 7, 2025, reporting as a foreign private issuer. The company, incorporated in France with its principal executive office in Paris, is involved in the biological products sector. This filing is made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates ongoing reporting requirements for Cellectis S.A. as a foreign private issuer, providing transparency to investors regarding its regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine regulatory report and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- October 7, 2025 (date) — Filing Date
- Paris, France (location) — Principal Executive Office
- 001-36891 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information that the registrant makes or is required to make public pursuant to the laws of its home country, or files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was this Form 6-K filed?
This Form 6-K was filed on October 7, 2025.
What is Cellectis S.A.'s principal executive office location?
Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Does Cellectis S.A. file annual reports under Form 20-F?
Yes, the filing indicates with a checkmark that Cellectis S.A. files annual reports under cover of Form 20-F.
What is Cellectis S.A.'s SIC code?
Cellectis S.A.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2025-10-07 06:00:12
Filing Documents
- f6k_100625.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-006308.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: October 7, 2025 /s/ Andr Choulika Andr Choulika Chief Executive Officer